come to Europe
We are European experts with a passion for helping people. It is our job to bring Curaleaf quality and innovation to Europe.
AND CANNABIS IS OUR CALLING.
Meet the leadership team
President, Curaleaf International
Chief Operating Officer
An experienced senior executive in the Global FMCG sector with exposure across a range of finance and general managerial competencies, both in FTSE 10 Corporate Head Office and more operationally dynamic environments.
Prior to joining EMMAC he was Finance Director of the Northern Europe Area at British American Tobacco operating in complex regulatory and commercial environments. The business unit spanned 11 markets and included Pharmaceutical and Next Generation Product operations, as well as traditional tobacco businesses.
Prior to British American Tobacco, he spent 6 years at PriceWaterhouseCoopers initially as an auditor before moving into the M&A and Transactions Finance competencies. He is a Qualified Chartered Account.
Chief Scientific Officer
Barbara Pacchetti is a seasoned executive with over 20 years of experience in the pharmaceutical and nutraceutical space in Europe and globally. Her length of industry experience has enabled her to develop expertise and leadership in areas such as Life Science research, Innovation and R&D, Process 11 technology, intellectual property and project management researching natural compounds and bioactives.
She has been responsible for scientific communication, including scientific publications, poster presentations, papers and lectures at congresses and symposiums and medical-marketing activities to support products development and sales.
She is the author or co-author of more than 60 scientific publications in the field of pharmaceutical science, of which 10 in the peer-reviews high impact-factor scientific journals. She is a named inventor on about 15 patents and patent applications in the field of pharmaceutical science.
Barbara holds a Masters Degree in Pharmaceutical Chemistry and Technology from University of Milan (1993) and in Pharmaceutical Sciences (1995), completed by post graduate Specialisation courses, Industrial Development (2001), Phototherapy (2003), Current Good Manufacturing Practice (cGMP, 2008), Health & Pharma Marketing (2013).
In the carrier job roles, she oversees innovation, research and development activities, life science activities (pharmacological, pre-clinical and clinical trials) and intellectual property.
Her high level of professional specialisation and expertise has been recognised through collaboration with scientific committee and institutional referee in European and Italian Universities and Research Centres.
Throughout her career, she has held various leadership roles and senior positions in leading European Companies committed to research and commercialisation of pharmaceuticals and nutraceuticals active ingredients and finished products. In over twenty years in the pharmaceutical and nutritional fields, she has built a broad based successful experience into the exploration and the monitoring of new trends related to wellness and illness treatment through natural bioactives.
Chief Financial Officer
Peter Doona is an experienced finance leader with a track record of delivering growth and transformation in Global FMCG and expertise in M&A and Commercial Finance.
Before joining Curaleaf International he was Head of Financial Planning and Analysis at BAT plc, responsible for delivery of Group results while reshaping financial planning and capital allocation towards growth of new product categories. During his 14 years with BAT he worked in a variety of finance roles including M&A, in which he was pivotal in the transformational merger with Reynolds American, and Finance Director positions in Kazakhstan and Zimbabwe.
Prior to BAT Peter spent 4 years at PwC in Transaction Services having qualified as a Chartered Accountant in External Audit at EY.
Chief Revenue Officer
Massimilliano is a passionate and seasoned business professional with over 20 years’ experience delivering business growth in the international Pharmaceutical industry.
Prior to joining EMMAC Life Sciences Group, Massimiliano held the position of Chief Commerical Officer at Linnea where, since 2015, he was responsible for rapidly developing the medical cannabis business.
Prior to this he was Head of International sales for Recordati with global responsibility and a special focus on Latin America and South East Asia, following on from 10 years at Chiesi Farmaceutici where he held the position of Business Area Manager for CIS countries and North America. Massimilliano graduated in Pharmaceutical Chemistry and completed his Executive MBA in 2012.
Dr Mikael Sodergren
Dr Mikael Sodergren is an academic clinician based at Imperial College London. His research interests include clinical translation of innovative technology, therapeutics and techniques in medicine, specialising in complex liver, pancreas and keyhole surgery. He serves on the editorial board for two prestigious medical journals and regularly reviews scientific research on behalf of about 50 different editorial teams.
He has authored over 90 peer reviewed journal publications and regularly presents his work at international forums. The high quality of research has been recognised in the mainstream media with appearances on BBC Radio 4 “Inside Health” and in the Daily Mail. Together with a group of NHS doctors he founded Sapphire Medical Clinics – a second opinion service for doctors to evaluate the appropriateness of medical cannabis for a range of clinical conditions.
Hannah Du Beke
Chief Marketing and Communications Officer
Hannah Du Beke is a proven business leader with a track record of delivering business growth through corporate positioning and market communication strategies worldwide. For the past 20 years Hannah has driven high impact, global marketing and corporate communication programmes across a broad range of industries, including, telecommunications, technology, pharmaceutical and not for profit organisations.
Managing Director Germany / Nordics
Andre Pass is a senior industry executive with a wealth of advertising, brand and digital sales experience and expertise in innovation processes and digital transformation.
Prior to joining EMMAC Germany, Andre was founder and managing director of a leading German agency group, working with many well-known clients in the fields of e-commerce, insurance and banking, and most recently in the medical cannabis market.
Andre joins EMMAC, as Managing Director of EMMAC’s German operations with a focus on leading scaling EMMAC’s operations in Germany
Anita Sekhri trained and qualified as a corporate lawyer with Allen & Overy, before moving in-house and has over fifteen years’ experience working in multinational organisations, predominantly in the life sciences industry.
As well as holding senior legal positions in-house, Anita has most recently worked as a freelance solicitor advising pharma clients on a variety of matters including early stage R&D and product licensing, clinical trials, manufacturing and supply arrangements as well as compliance with pharma industry codes. Anita is also an experienced data protection and privacy professional.
Managing Director, Medical Cannabis Germany
Julian Vaterrodt is an experienced entrepreneur with a successful track record of business consultancy for a wide range of clients, including the German Government.
Most recently Julian managed the design and implementation of Medical Cannabis sales, logistics and marketing programmes for CC Pharma GmbH, a large pharmaceutical distributor in Germany. He is well respected figure in the European Cannabis industry, a frequent speaker at industry events and is joining EMMAC as Managing Director of Medical Cannabis Operations – About Nature Health GmbH.
Managing Director France / Benelux
François-Xavier Nottin is a senior marketing executive with extensive experience in digital P&L management. Specialising in high impact marketing strategies, Francois-Xavier is data-driven and brand oriented, a champion of progressive marketing concepts with a proven track record managing digital business transformation, generating revenue growth, increasing market share, and delivering key performance metrics across a number of industries.
Francois-Xavier started his career with Carat-Interactive in Paris, before time as European Marketing Director for AOL, General Manager for BWIN in France & Belgium, and most recently as Sports Betting Director for FDJ in Paris.
Managing Director, Switzerland
A respected cannabis professional with experience in North America and Europe and specializing in cultivation and breeding techniques. Before joining EMMAC, Roberto launched and managed De Rerum Natura, a cannabis cultivation company in Switzerland.
Prior to his career in cannabis, Roberto worked for multiple organisations in the commodities and food industries, holding various commercial and operational senior positions in multiple jurisdictions, in Europe, Asia and Africa. A Spanish citizen, Roberto lives in Switzerland and is fluent in 4 languages.
Managing Director, Spain
Javier is a senior Pharma executive and entrepreneur with more than 20 years experience in building and running successful companies.
The holder of a PHD in Chemistry from the University of Madrid, Javier was also an Associate Professor of organic chemistry at the University of Alicante.
He co-founded and currently manages Medalchemy, a GMP-certified manufacturer of Active Pharmaceutical Ingredients.
Head of Supply Chain
Phil Birch is an experienced operational professional with 12 years experience in global FMCG Supply Chain. Graduating from Warwick University with a masters in supply chain and logistics, Phil worked for British American Tobacco in a variety of roles both in the group supply chain service center and also in various end markets within Europe, the Middle East and Africa.
Phil has extensive experience of working in highly regulated environments both in the Wellness sector and pharmaceutical sector.
General Manager, Portugal
Nuno is a skilled manager, with over twenty years’ experience in pharmaceutical operations.
Nuno has managed a number of business-critical projects, ranging from high profile capital investments and industrial engineering implementations to the design, commissioning and set up of several production units, including two bio-pharmaceutical plants. Later on, has played senior management roles in industrial business areas, focusing both on strategic, commercial and operational levels.
Nuno holds an MBA with major in finance (listed among Financial Times Global MBA ranking 2021) and a Black Belt in Lean-Six-Sigma by Lockheed Martin Corp. & HCA.
Head of HR
Kelly is a multi-skilled HR leader, with 10 years HR and recruitment experience across regulated financial services. She is a confidant and advisor to senior leadership teams to drive strong group performance.
As an HR professional, she is passionate about all things people orientated, has experience in scaling small, privately owned companies and building robust, operational HR processes.
UK Country Manager
Jonathan Co-Founded Rokshaw Laboratories in 2012, having been in the healthcare sector since 1999, holding senior sales and marketing roles at Smiths Medical, Johnson & Johnson and Cardinal Health.
UK Country Manager
Richard Co-Founded Rokshaw Laboratories in 2012, having been in the healthcare sector since 1999, holding senior sales and marketing roles at Smiths Medical, Johnson & Johnson and Cardinal Health.
Group Quality Assurance Manager
Pierluca is a passionate and experienced MD Pharmaceutical Chemist and Pharmacist with over 10 years’ experience working in multinational pharmaceutical industry.
Prior to joining Curaleaf International, Pierluca held various roles and positions at Novartis Pharmaceuticals. During his career he has led several departments responsible for the manufacturing, quality control and quality assurance of medical cannabis and in addition for solid, sterile, radioligand nuclear medicine finished products.
Pierluca is experienced working in a multicultural and highly regulated environment, setting the highest qualitative standard to guarantee the quality, efficacy and safety of products.